The stock is about 20 and started the year about 30. The company initiates a poison pill. No reason, they just thought it was a good idea. not a great vote of confidence in the firm.
Who's on this board? None of these people seem suspicious (yet).
Max Link, Ph.D. - Chairman
Samuel Broder, M.D. - Chief Medical Officer, Celera Genomics and Celera Diagnostics
Karen A. Dawes - Principal, Knowledgeable Decisions, LLC
L. Patrick Gage, Ph.D. - Director
Bradford S. Goodwin - Director
Laurence Jay Korn, Ph.D. - Director
Mark McDade - Chief Executive Officer
Jon S. Saxe, Esq. - President, Saxe Associates
No comments:
Post a Comment